Metabolic Syndrome
Type 2 is uncommon at 15 years without obesity/metabolic syndrome context.
What our notes say
- Type 2 is uncommon at 15 years without obesity/metabolic syndrome context. (Chemical Pathology MCQs: Diabetes, Renal & Liver Disease)
- | Second-generation antipsychotics | Olanzapine, risperidone, quetiapine, lurasidone | Metabolic syndrome, prolactin (risperidone) | (Introduction to Psychopharmacology)
- Treat comorbid anxiety and substance use; manage physical health (metabolic syndrome). (Bipolar and Related Disorders)
- Physical health: cardiovascular disease, diabetes and metabolic syndrome; 10–20 years reduced life expectancy. (Bipolar and Related Disorders)
- | Non‑alcoholic steatohepatitis | Metabolic syndrome, ultrasound fatty liver, ALT modestly ↑ | Imaging shows steatosis, absence of viral markers, normal HBV DNA | (Hepatitis B and the approach to hepatitis)
- Endocrinology and metabolism — diabetes mellitus; DKA and HHS; hypoglycaemia; hypothyroidism and thyrotoxicosis; thyroid storm and myxoedema coma; adrenal insufficiency and Cushing syndrome; calcium and parathyroid disorders; pituitary disease; obesity and metabolic syndrome. (Year 4 Internal Medicine: Exam Revision Roadmap)
Study material on Metabolic Syndrome
- Obesity and metabolic syndrome
- Chemical Pathology MCQs: Clinical Chemistry, Endocrine & Renal
- Introduction to Psychopharmacology
- Chemical Pathology MCQs
Practice questions on Metabolic Syndrome
Metabolic syndrome diagnosis requires at least 3 of 5 criteria. These are
- Central obesity, hypertension, elevated triglycerides, low HDL, elevated fasting glucose
- Fever, leukocytosis, raised CRP, elevated ESR, lymphocytosis
- Peripheral edema, proteinuria, elevated LDL, hyperkalemia, high renin
- Hypoglycaemia, bradycardia, low LDL, underweight, low blood pressure
Answer: A. Greatly increases CV risk and T2DM risk. Associated with NAFLD, PCOS, sleep apnoea.